Reuters -- France’s Sanofi-Aventis said the results of a study on the link between its Lantus diabetes drug and retinopathy, which causes blindness, showed the risk for patients was not greater than with human insulin.
Reuters -- France’s Sanofi-Aventis said the results of a study on the link between its Lantus diabetes drug and retinopathy, which causes blindness, showed the risk for patients was not greater than with human insulin.
